November 28, 2022
You are here:  Home  >  'Evenityu'

Amgen gets go-ahead on two drugs

By   /  Friday, October 18th, 2019  /  Latest news  /  Comments Off on Amgen gets go-ahead on two drugs

Regulators handed Amgen two victories for its drug portfolio, granting the Thousand Oaks biotech giant approval to treat a wider range of patients with osteoporosis and blood disorders. The U.S. Food and Drug Administration approved the use of Amgen’s immune thrombocytopenia drug Nplate for earlier use in adults Oct. 18, allowing it to be given Read More →